Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. Ko M, Jeon S, Ryu WS, Kim S, et al. J Med Virol 2020 Aug 7. doi: 10.1002/jmv.26397.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ko M, Jeon S, Ryu WS, Kim S, et al. Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol 2020 Aug 7. doi: 10.1002/jmv.26397.
PMID: 32767684